B
BIOVOX
Biotech & Life Sciences · Darmstadt, Germany · Founded 2020
Future-proof, sustainable plastics for healthcare MoreLess
BIOVOX is a German company founded in 2021 that develops and produces sustainable, medical-grade bioplastic compounds for the healthcare, pharmaceutical, and laboratory sectors. The company aims to address the significant carbon footprint of the healthcare industry, where single-use plastics are prevalent. BIOVOX's materials are designed to be a safe, recyclable, and bio-based alternative to conventional fossil-based plastics, reducing CO2 emissions by up to 85%.
The company was founded by Dr. Julian Lotz (CEO), Carmen Rommel (COO), and Dr. Vinzenz Nienhaus (CTO), all of whom are mechanical engineers from the Technical University of Darmstadt. Their collective background in plastics technology, sustainable product development, and medical technology spurred the idea to tackle plastic waste in clinical settings. The initial concept emerged around 2018, leading to the official founding in late 2020. In September 2024, BIOVOX successfully closed a €2.2 million seed funding round led by High-Tech Gründerfonds (HTGF) to scale operations and establish a proprietary technical center.
BIOVOX operates on a B2B model, selling its specialized MedEco thermoplastic granules to medical device manufacturers. These materials are compliant with medical industry standards, including ISO 13485, and are tested for biocompatibility according to ISO 10993. The product portfolio includes materials with a range of properties, such as rigidity or softness, transparency, and suitability for various manufacturing processes like injection molding and 3D printing. Applications for their bioplastics include surgical instruments, disposables, packaging, and drug delivery devices. By offering a sustainable and regulatory-compliant material, BIOVOX enables its clients, which number over 50, to develop products for a circular economy without compromising on patient safety or performance.
Keywords: medical-grade bioplastics, sustainable materials, circular economy, healthcare plastics, biocompatible polymers, medtech, pharmaceutical packaging, laboratory consumables, renewable materials, carbon footprint reduction
Company overview
BIOVOX company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2020
- Headquarters
- Darmstadt, Germany
- Employees
- 17
- Open positions
- 1
- Dealroom signal
- 62.3
Valuation & funding
BIOVOX funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SEED✓Equity / VC | Sep 2024 | $2.4M | $9.7M | HTGF · Auxxo Female Catalyst Fund · BMH | ↗ |
| SEEDEquity / VC | Apr 2022 | — | — | better ventures | — |
| SUPPORT PROGRAM✓Other financing | Jan 2022 | $0 | — | Undisclosed | — |
| SEEDEquity / VC | Sep 2021 | $0 | — | Undisclosed | — |
| SPINOUT✓Other financing | Feb 2020 | $0 | — | Technical University of Darmstadt | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 17 |
| 2025 | 18 |
| 2024 | 13 |
| 2023 | 10 |
| 2022 | 5 |
| 2021 | 5 |
Growth signals
BIOVOX website traffic
Latest recorded traffic for BIOVOX is 860 monthly website visits, up 56.4% over the last three months. BIOVOX's team declined 5.6% over the past year.
Hiring
Open positions at BIOVOX
Current openings linked to this company in Dealroom.
Comparisons
BIOVOX compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
BIOVOX's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where BIOVOX has talent and traffic
team presence
In the news
Latest news about BIOVOX
Recent press, funding announcements, and product moves mentioning BIOVOX — open to read from the original sources.
Market sentiment
What the market is saying about BIOVOX
An AI-synthesized read of the highest-engagement posts about BIOVOX on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See BIOVOX’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.